China National Accord Medicines Corp Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: -0.020x

China National Accord Medicines Corp Ltd cash flow conversion efficiency. Based on the latest financial reports, China National Accord Medicines Corp Ltd (200028) has a cash flow conversion efficiency ratio of -0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (HK$-424.00 Million ≈ $-54.13 Million USD) by net assets (HK$21.55 Billion ≈ $2.75 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of China National Accord Medicines Corp Ltd (1998–2025)

Cash flow conversion efficiency of China National Accord Medicines Corp Ltd from 1998 to 2025. This chart illustrates how China National Accord Medicines Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of China National Accord Medicines Corp Ltd for real-time trading data and today's change.

China National Accord Medicines Corp Ltd Cash Flow Conversion Ratio Explained

China National Accord Medicines Corp Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

China National Accord Medicines Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of China National Accord Medicines Corp Ltd ranked by their cash flow conversion efficiency. Also see 200028 stock market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Mega Uranium Ltd. TO:MGA	-0.005x
Grigeo AB STU:WM8	0.060x
Group Eleven Resources Corp V:ZNG	-0.080x
Taiwan Fructose Co Ltd TWO:4207	0.023x
Carnarvon Energy Ltd AU:CVN	0.000x
Global Dividend Growth Split Corp Class A TO:GDV	0.008x
Securitag Assembly Group Co Ltd TWO:6417	0.023x
Avita Medical Ltd NASDAQ:RCEL	0.327x

Annual Cash Flow Conversion Efficiency for China National Accord Medicines Corp Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of China National Accord Medicines Corp Ltd from 1998 to 2025. Review 200028 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	HK$21.62 Billion ≈ $2.76 Billion	HK$1.64 Billion ≈ $209.17 Million	0.076x	-51.93%
2024-12-31	HK$20.76 Billion ≈ $2.65 Billion	HK$3.27 Billion ≈ $417.62 Million	0.158x	+12.58%
2023-12-31	HK$20.98 Billion ≈ $2.68 Billion	HK$2.94 Billion ≈ $374.94 Million	0.140x	+6.33%
2022-12-31	HK$19.44 Billion ≈ $2.48 Billion	HK$2.56 Billion ≈ $326.85 Million	0.132x	+43.38%
2021-12-31	HK$18.02 Billion ≈ $2.30 Billion	HK$1.66 Billion ≈ $211.29 Million	0.092x	+3.22%
2020-12-31	HK$16.89 Billion ≈ $2.16 Billion	HK$1.50 Billion ≈ $191.83 Million	0.089x	-31.68%
2019-12-31	HK$15.36 Billion ≈ $1.96 Billion	HK$2.00 Billion ≈ $255.35 Million	0.130x	+36.93%
2018-12-31	HK$13.91 Billion ≈ $1.78 Billion	HK$1.32 Billion ≈ $168.84 Million	0.095x	-26.54%
2017-12-31	HK$9.93 Billion ≈ $1.27 Billion	HK$1.29 Billion ≈ $164.07 Million	0.129x	-21.63%
2016-12-31	HK$8.91 Billion ≈ $1.14 Billion	HK$1.47 Billion ≈ $187.98 Million	0.165x	-12.25%
2015-12-31	HK$5.57 Billion ≈ $710.58 Million	HK$1.05 Billion ≈ $133.78 Million	0.188x	+214.64%
2014-12-31	HK$4.85 Billion ≈ $619.28 Million	HK$-796.70 Million ≈ $-101.70 Million	-0.164x	-181.81%
2013-12-31	HK$2.32 Billion ≈ $295.73 Million	HK$465.03 Million ≈ $59.36 Million	0.201x	+13.95%
2012-12-31	HK$1.84 Billion ≈ $234.76 Million	HK$323.96 Million ≈ $41.35 Million	0.176x	+10.57%
2011-12-31	HK$1.43 Billion ≈ $182.14 Million	HK$227.32 Million ≈ $29.02 Million	0.159x	-57.90%
2010-12-31	HK$1.13 Billion ≈ $144.43 Million	HK$428.16 Million ≈ $54.66 Million	0.378x	+22.69%
2009-12-31	HK$878.13 Million ≈ $112.10 Million	HK$270.85 Million ≈ $34.57 Million	0.308x	-18.77%
2008-12-31	HK$649.37 Million ≈ $82.89 Million	HK$246.58 Million ≈ $31.48 Million	0.380x	+124.10%
2007-12-31	HK$517.58 Million ≈ $66.07 Million	HK$87.70 Million ≈ $11.20 Million	0.169x	-55.91%
2006-12-31	HK$472.90 Million ≈ $60.37 Million	HK$181.73 Million ≈ $23.20 Million	0.384x	+2.04%
2005-12-31	HK$393.72 Million ≈ $50.26 Million	HK$148.28 Million ≈ $18.93 Million	0.377x	+3.53%
2004-12-31	HK$358.20 Million ≈ $45.73 Million	HK$130.30 Million ≈ $16.63 Million	0.364x	+53.55%
2003-12-31	HK$342.86 Million ≈ $43.77 Million	HK$81.22 Million ≈ $10.37 Million	0.237x	+175.64%
2002-12-31	HK$334.70 Million ≈ $42.73 Million	HK$28.76 Million ≈ $3.67 Million	0.086x	-55.98%
2001-12-31	HK$364.45 Million ≈ $46.52 Million	HK$71.16 Million ≈ $9.08 Million	0.195x	+828.36%
2000-12-31	HK$405.06 Million ≈ $51.71 Million	HK$8.52 Million ≈ $1.09 Million	0.021x	-58.36%
1999-12-31	HK$452.23 Million ≈ $57.73 Million	HK$22.84 Million ≈ $2.92 Million	0.051x	+334.65%
1998-12-31	HK$448.25 Million ≈ $57.22 Million	HK$5.21 Million ≈ $664.85K	0.012x	--

About China National Accord Medicines Corp Ltd

SHE:200028 China Medical Distribution

Market Cap

$126.64 Million

HK$992.07 Million HKD

Market Cap Rank

#18074 Global

#4658 in China

Share Price

HK$12.64

Change (1 day)

-0.24%

52-Week Range

HK$11.60 - HK$14.07

All Time High

HK$1125.97